✦ LIBER ✦

Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer

✍ Scribed by T. Brodowicz; W.J. Kostler; R. Möslinger; S. Tomek; I. Vaclavik; V. Herscovici; C. Wiltschke; G.G. Steger; W. Wein; M. Seifert; E. Kubista; C.C. Zielinski

Book ID: 114482648
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 131 KB
Volume: 9
Category: Article
ISSN: 0960-9776
DOI: 10.1054/brst.2000.0170

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single-agent gemcitabine as second- and

Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer

✍ W.J. Köstler; T. Brodowicz; R. Möslinger; S. Tomek; I. Vaclavik; V. Herscovici; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Second- and third-line treament of metas

Second- and third-line treament of metastatic breast cancer with gemcitabine

✍ T. Brodowicz; R. Möslinger; V. Herscovici; I. Vaclavik; C. Wiltschke; E. Kubista 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Second-line treatment of ovarian cancer

Second-line treatment of ovarian cancer with single-agent gemcitabine

✍ Maurie Markman 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Gemcitabine and vinorelbine as second-li

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

✍ Michela Donadio; Mara Ardine; Alfredo Berruti; Giuliana Ritorto; Elena Fea; Mari 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 179 KB

Gemcitabine (GEM) as single agent in sec

Gemcitabine (GEM) as single agent in second line treatment of non-small cell lung cancer (NSCLC)

✍ Mahjoubi, R; Llory, J.F; Brugière, O; Vannetzel, J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Gemcitabine (GEM) as single agent in sec

Gemcitabine (GEM) as single agent in second line treatment of non-small cell lung cancer (NSCL)

✍ Mahjoubi, R; Llory, J; Brugiere, O; Vannetzel, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB